Proof of Concept: Microinvasive AngioVac Approach in Renal Cell Carcinoma With Atrial Thrombosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 33676906.
- Also identified by DOI 10.1016/j.athoracsur.2020.11.093.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The AngioVac system (AngioDynamics, Latham, NY) has already been described for treatment of thrombotic formations concerning the venous district and the tricuspid valve. We describe an innovative application of the AngioVac system to treat the inferior vena cava thrombosis associated with renal cell carcinoma. In a high surgical risk patient, we utilized a microinvasive and a modified venoarterial AngioVac circuit to remove the atrial thrombus, ensure temporary circulatory support during abdominal surgery, and prevent pulmonary embolism.
Medical subject headings
- Carcinoma, Renal Cell
- Heart Diseases
- Kidney Neoplasms
- Neoplastic Cells, Circulating
- Thrombosis
- Vena Cava, Inferior